NOVONIX Limited (ASX:NVX) (FRA:GC3) (OTCMKTS:NVNXF) is an integrated developer and supplier of high-performance materials, equipment and services for the global lithium-ion battery industry with operations in the USA and Canada and sales in more than 14 countries. NOVONIX's mission is to support the global deployment of lithium-ion battery technologies for a cleaner energy future.
NOVONIX Limited (ASX:NVX) (FRA:GC3) provides an update regarding overseas trading in the Company's shares following further inbound enquiries from investors from North America and Europe.
NOVONIX Limited (ASX:NVX) (FRA:GC3) is pleased to advise that following Shareholder approval at a General Meeting of Shareholders this morning, the Equity Raising announced on 29 May 2020 is now complete with $63 million having been raised.
NOVONIX Limited (ASX:NVX) (FRA:GC3) refers to the equity raising announced on 27 May 2020, which included an institutional placement to raise $5.65 million and an entitlement offer to raise approximately $37.91 million.
NOVONIX Limited (ASX:NVX) (FRA:GC3) is pleased to advise that parties who were unable to attend the investor webinar broadcast today can watch and replay a recording of the full presentation
NOVONIX Ltd (ASX:NVX) WHAT'S NEXT? NOVONIX Technology Roadmap
NOVONIX Limited (ASX:NVX) (FRA:GC3) provides update regarding international trading in its shares following increasing levels of inbound enquiry from investors from North America and Europe during the month of June.
NOVONIX Limited (ASX:NVX) (FRA:GC3) wishes to advise it will host an investor webinar on Friday 12th June, 2020 at 10.15am AEST to discuss the recent announcement regarding its ability to manufacture single crystal NMC cathode material.
NOVONIX Limited (ASX:NVX) (FRA:GC3), in partnership with the Professor Mark Obrovac Research Group at Dalhousie University, is pleased to announce its ability to manufacture "single crystal" NMC cathode material using its proprietary Dry Particle Microgranulation (DPMG) technique.
NOVONIX Limited (ASX:NVX) (FRA:GC3) is conducting a fully underwritten ~$58.28 million equity raising
NOVONIX Limited (ASX:NVX) (FRA:GC3) is pleased to announce a significant $58.28 million capital raising, including a proposed institutional placement, a strategic placement and a rights issue to Australian and New Zealand NOVONIX shareholders, at an issue price of $0.29 per new share.
